The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C

Journal of Neurochemistry

Volumn 74, Issue 6, 2000, Pages 2268-2277

  Bastianetto, Stéphane ^a   Zheng, Wen Hua ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Flavonoids; Ginkgo biloba extract (EGb 761); Hippocampal cells; Ischemia; Neuroprotection; Nitric oxide; Protein kinase C

Indexed keywords

BILOBALIDE; CALCIUM CHANNEL; CHELERYTHRINE; FLAVONOID; FREE RADICAL; GINKGO BILOBA EXTRACT; GINKGOLIDE B; LINSIDOMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHOLIPASE INHIBITOR; PROTEIN KINASE C INHIBITOR; TERPENOID;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FETUS; HIPPOCAMPUS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKALOIDS; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; AZOLES; BENZOPHENANTHRIDINES; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; DITERPENES; ENZYME INHIBITORS; ESTRENES; FLAVONOIDS; FREE RADICAL SCAVENGERS; GINKGO BILOBA; GINKGOLIDES; HIPPOCAMPUS; LACTONES; MOLSIDOMINE; NEURONS; NEUROPROTECTIVE AGENTS; NITRENDIPINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; PHENANTHRIDINES; PHOSPHODIESTERASE INHIBITORS; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTEIN KINASE C; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

ANIMALIA; GINKGO BILOBA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0034122940     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0742268.x     Document Type: Article

References (71)

1. Abbracchio M. P., Brambilla R., Ceruti S., Kim H. O., Von Lubitz D. K., Jacobson K. A., and Cattabeni F. (1995) G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol. Pharmacol. 48, 1038-1045.
2. Alonso R., Poirier J., O'Donnell D., Buisson N., Diorio J., Boksa P., and Quirion R. (1994) Statin, a marker of cell cycle arrest, is overexpressed during the early phase of delayed NMDA toxicity in hippocampal cell cultures. Mol. Cell. Neurosci. 5, 530-539.
3. Arteel G. E., Briviba K., and Sies H. (1999) Protection against peroxynitrite. FEBS Lett. 445, 226-230.
4. Backhauss C., Karkoutly C., Welsch M., and Krieglstein J. (1992) A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmacol. Methods 27, 27-32.
5. Barth S. A., Inselmann G., Engemann R., and Heidemann H. T. (1991) Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochem. Pharmacol. 41, 1521-1526.
6. Bastianetto S., Ramassamy C., Christen Y., Poirier J., and Quirion R. (1998) Ginkgo biloba extract (EGb 761) protects in vitro rat hippocampal cells against toxicity induced by β-amyloid peptides. Soc. Neurosci. Abstr. 24, 1456.
7. Bastianetto S., Ramassamy C., Poirier J., and Quirion R. (1999) Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Mol. Brain Res. 66, 35-41.
8. Bazan N. G. and Rodriguez de Turco E. B. (1993) Accumulation of lipid-derived second messengers during seizures and ischemia: decreased seizure-induced phospholipase C activation in the hippocampus by EGb 761, in Advances in Ginkgo biloba Extract Research. Effect of Ginkgo biloba Extract (EGb 761) on the Central Nervous System (Christen Y., Costentin J., and Lacour M., eds), pp. 159-169. Elsevier, Paris.
9. Behar-Cohen F. F., Heydolph S., Faure V., Droy-Lefaix M. T., Courtois Y., and Goureau O. (1996) Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem. Biophys. Res. Commun. 226, 842-849.
10. Bondy S. C. and Naderi S. (1994) The formation of reactive oxygen species in a fraction of rat brain by metabolism of nitric oxide. Neurosci. Lett. 168, 34-36.
11. 2+ homeostasis in hippocampal neurons. J. Neurochem. 68, 95-105.
12. Cardell M., Bingren H., Wieloch T., Zivin J., and Saitoh T. (1990) Protein kinase C is translocated to cell membranes during cerebral ischemia. Neurosci. Lett. 119, 228-232.
13. Crow J. P. and Beckman J. S. (1996) The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv. Exp. Med. Biol. 387, 147-161.
14. Dawson V. L. and Dawson T. M. (1996) Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10, 179-190.
15. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
16. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., and Snyder S. H. (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
17. Denizot F. and Lang R. (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271-277.
18. Doré S., Kar S., and Quirion R. (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. USA 94, 4772-4777.
19. Draize J. H., Woodard G., and Calvery H. O. (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82, 377-390.
20. Drieu K. (1986) Preparation and definition of Ginkgo biloba extract. Presse Med. 15, 1455-1457.
21. Droy-Lefaix M. T., Menerath J. M., Szabo-Tosaki E., Guillaumin D., and Doly M. (1995) Protective effect of EGb 761 on ischemia-reperfusion damage in the rat retina. Transplant. Proc. 27, 2861-2862.
22. Fautz R., Husein B., and Hechenberger C. (1991) Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS). Mutat. Res. 253, 173-179.
23. - . free radicals. A γ-radiolysis study. Free Radic. Biol. Med. 9, 190.
24. Gonzalez-Zulueta M., Ensz L. M., Mukhina G., Lebovitz R. M., Zwacka R. M., Engelhardt J. F., Oberley L. W., Dawson V. L., and Dawson T. M. (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18, 2040-2055.
25. 3H]phorbol 12,13-dibutyrate. Neurosci. Lett. 120, 120-123.
26. Hofferberth B. (1994) The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type: a double-blind, placebo-controlled study on different levels of investigation. Hum. Psychopharmacol. 9, 215-222.
27. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., and Moskowitz M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
28. Hyman B. T., Van Hoesen G. W., Damasio A. R., and Barnes C. L. (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225, 1168-1170.
29. Iadecola C. (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20, 132-139.
30. Karcher L., Zagermann P., and Krieglstein J. (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn Schmiedebergs Arch. Pharmacol. 327, 31-35.
31. Kinouchi H., Epstein C. J., Mizui T., Carlson E., Chen S. F., and Chan P. H. (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. USA 88, 11158-11162.
32. Kleijnen J. and Knipschild P. (1992) Ginkgo biloba. Lancet 340, 1136-1139.
33. 2 inhibitor? Naunyn Schmiedebergs Arch. Pharmacol. 351, R86.
34. Klein J., Chatterjee S. S., and Löffelholz K. (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res. 755, 347-350.
35. Kramer R. M., Stephenson D. T., Roberts E. F., and Clemens J. A. (1996) Cytosolic phospholipase A2 (cPLA2) and lipid mediator release in the brain. J. Lipid Mediat. Cell Signal. 14, 3-7.
36. Krieglstein J., Ausmeier F., El-Abhar H., Lippert K., Welsch M., Rupalla K., and Henrich-Noack P. (1995) Neuroprotective effects of Ginkgo biloba constituents. Eur. J. Pharmaceut. Sci. 3, 39-48.
37. Kuppusamy P., Ohnishi S. T., Numagami Y., Ohnishi T., and Zweier J. L. (1995) Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia. J. Cereb. Blood Flow Metab. 15, 899-903.
38. Larsen R. G., Dupeyron J. P., and Boulu R. G. (1978) Modèles d'ischémie cérébrale expérimentale par microsphères chez le rat. Etude de l'effet de deux extraits de Ginkgo biloba du naftidrofuryl. Therapie 33, 651-660.
39. Le Bars P., Katz M. M., Nancy B., Itil T. M., Freedman A. M., and Schatzberg A. F. (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278, 1327-1332.
40. Maiese K. (1998) From the bench to the bedside: the molecular management of cerebral ischemia. Clin. Neuropharmacol. 21, 1-7.
41. Maiese K., Boniece I., DeMeo D., and Wagner J. A. (1993a) Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13, 3034-3040.
42. Maiese K., Boniece I., Skurat K., and Wagner J. A. (1993b) Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J. Neurosci. Res. 36, 77-87.
43. Maiese K., Wagner J. A., and Boccone L. (1994) Nitric oxide: a down-stream mediator of calcium toxicity in the ischemic cascade. Neurosci. Lett. 166, 43-47.
44. Maiese K., TenBroeke M., and Kue I. (1997) Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J. Neurochem. 68, 710-714.
45. Marcocci L., Maguire J. J., Droy-Lefaix M. T., and Packer L. (1994a) The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 201, 748-755.
46. Marcocci L., Packer L., Droy-Lefaix M. T., Sekaki A., and Gardes-Albert M. (1994b) Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 234, 462-475.
47. Mattson M. P. (1997) Neuroprotective signal transduction: relevance to stroke. Neurosci. Biobehav. Rev. 21, 193-206.
48. Mattson M. P., Barger S. W., Begley J. G., and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187-216.
49. Maurer K., Ihl R., Dierks T., and Frölich L. (1997) Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J. Psychiatr. Res. 31, 645-655.
50. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387.
51. Middleton E. and Kandaswamy C. (1993) The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer, in The Flavonoids: Advances in Research Since 1986 (Harbone J. B., ed), pp. 619-652. Chapman & Hall, London.
52. Oberpichler H., Beck T., Abdel-Rahman M. M., Bielenberg B. W., and Krieglstein J. (1988) Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol. Res. Commun. 20, 349-368.
53. Oberpichler H., Sauer D., Rossberg C., Mennel H. D., and Krieglstein J. (1990) PAF-antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J. Cereb. Blood Flow Metab. 10, 133-135.
54. 2+-induced increase in oxidative metabolism of dissociated mammalian brain neurons: effect of extract of Ginkgo biloba leaves. Jpn. J. Pharmacol. 61, 367-370.
55. 2+-loaded brain neurons. Brain Res. 635, 125-129.
56. Oyama Y., Chikahisa L., Ueha T., Kanemaru K., and Noda K. (1996) Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 712, 349-352.
57. Packer L., Haramaki N., Kawabata T., Marcocci L., Maitra I., Maguire J. J., Droy-Lefaix M. T., Sekaki A. H., and Gardès-Albert M. (1995) Ginkgo biloba extract (EGb 761): antioxidant action and prevention of oxidative stress-induced injury, in Advances in Ginkgo biloba Extract Research, Vol. 4: Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders (Christen Y., Courtois Y. and Droy-Lefaix M. T., eds), pp. 17-47. Elsevier, Paris.
58. Panetta T., Marcheselli V. L., Braquet P., Spinnewyn B., and Bazan N. G. (1987) Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem. Biophys. Res. Commun. 149, 580-587.
59. Prehn J. H. M. and Krieglstein J. (1993) Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J. Neurosci. Res. 34, 179-188.
60. Radi R., Beckman J. S., Bush K. M., and Freeman B. A. (1991) Peroxynitrite induced membrane lipid peroxidation. The cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487.
61. Rai G. S., Sholvin C., and Wesner K. A. (1991) A double-blind, placebo-controlled study of Ginkgo biloba extract in elderly out-patients with mild to moderate memory impairment. Curr. Med. Res. Opin. 12, 350-355.
62. 2+ induced decrease in membrane fluidity. Free Radic. Res. Commun. 19, 341-350.
63. Rodriguez de Turco E. B., Droy-Lefaix M. T., and Bazan N. G. (1993) Decreased electroconvulsive shock-induced diacylglycerols and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): selective effect in hippocampus as compared with cerebral cortex. J. Neurochem. 61, 1438-1444.
64. Rogue P. and Malviya A. N. (1996) Inhibition of protein kinase C by Ginkgo biloba extract (EGb 761), in Advances in Ginkgo biloba Extract Research, Vol. 5: Effects of Ginkgo biloba Extract (EGb 761) on Neuronal Plasticity (Christen Y., Droy-Lefaix M. T., and Macias-Nuñez J. F., eds), pp. 1-6. Elsevier, Paris.
65. Schmidt-Kastner R. and Freund T. F. (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40, 599-636.
66. Seif-El-Nasr M. and El-Fattah A. A. (1995) Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: effect of Ginkgo biloba extract. Pharmacol. Res. 32, 273-278.
67. Smith P. F., Maclennan K., and Darlington C. L. (1996) The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J. Ethnopharmacol. 50, 131-139.
68. Spinnewyn B., Blavet N., and Clostre F. (1986) Effet de l'extrait de Ginkgo biloba sur un modèle d'ischémie cérébrale chez la gerbille. Presse Med. 15, 1511-1515.
69. Szabo M. E., Droy-Lefaix M. T., and Doly M. (1997) Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. Clin. Neurosci. 4, 240-245.
70. Wesner K., Simmons D., Rook M., and Simpson P. (1987) A double blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum. Psychopharmacol. 2, 159-169.
71. Zablocka B., Lukasiuk K., Lazarewicz J. W., and Domanska-Janik K. (1995) Modulation of ischemic signal by antagonists of N-methyl-D-aspartate, nitric oxide synthase, and platelet-activating factor in gerbil hippocampus. J. Neurosci. Res. 40, 233-240.